Connect Biopharma
NASDAQ: CNTBSan Diego, US · 2 known investors
Find your way into Connect Biopharma
Connect Biopharma is a clinical-stage biopharmaceutical company developing antibody-based therapies targeting inflammatory diseases such as atopic dermatitis and asthma. The company operates globally with headquarters in San Diego and operations in the U.S. and China.
Founders & leadership
BD
Barry D. QuartinChief Executive OfficerBarry D. Quart is Chief Executive Officer and Director of Connect Biopharma. He has over 30 years of experience in biotechnology and pharmaceutical development, including 16 years as a public biotech CEO; he co-founded Ardea Biosciences in 2006 and served as its CEO until its acquisition by AstraZeneca in 2012, and most recently led Heron Therapeutics as CEO overseeing the development and launch of multiple drugs. He holds a Pharm.D. from the University of California, San Francisco.
DS
David SzekeresinPresidentDavid Szekeres is President of Connect Biopharma, a clinical-stage biopharmaceutical company developing antibody-based therapies for inflammatory diseases. He has held executive roles spanning operations, commercial, corporate development, strategy, finance, investor relations, and legal functions.
KJ
Kimberly J. ManhardinChief Development Officer, Executive VPKimberly J. Manhard serves as Executive Vice President and Chief Development Officer at Connect Biopharma, a clinical-stage biopharmaceutical company developing antibody-based therapies for inflammatory diseases. She brings experience in pharmaceutical drug development and corporate governance within the biotechnology sector.
Investors · 2
In the news
Connect Biopharma posts higher R&D and wider loss | CNTB Quarterly Report (10-Q)stocktitan.net · Aug 2026
Connect Biopharma completes enrollment in two asthma, COPD studiesstocktitan.net · Aug 2026Frequently asked questions
- What does Connect Biopharma do?
- Connect Biopharma is a clinical-stage biopharmaceutical company developing antibody-based therapies targeting inflammatory diseases such as atopic dermatitis and asthma. The company operates globally with headquarters in San Diego and operations in the U.S. and China.
- Who are Connect Biopharma's investors?
- Connect Biopharma's investors include Co-Win Ventures, RA Capital.
- Where is Connect Biopharma headquartered?
- Connect Biopharma is headquartered in San Diego, US.